Lokelma Patient Tips
Medically reviewed by Leigh Ann Anderson, PharmD. Last updated on June 18, 2025.
1. How it works
- Lokelma (sodium zirconium cyclosilicate) works by binding to potassium (K+) in the small and large intestines to help remove it from the blood. The potassium is then excreted by your body. Lokelma is given as an oral medicine to treat high potassium levels in the blood (known as hyperkalemia) in adults. It is designed to remove potassium and not calcium and magnesium.
- Lokelma exchanges potassium for hydrogen and sodium in the digestive tract so that the potassium does not enter the bloodstream. These types of drugs are often called "potassium binders". It is classified as a cation exchange resin. Lokelma is also not absorbed into your bloodstream.
- Potassium is a nutrient that your body needs for your muscles, nerves, heart, digestion and bone health. The kidneys normally remove potassium from the blood to help maintain an even balance. If the kidneys lose this ability, the levels of your potassium can get dangerously high. If you receive hemodialysis, potassium can also rise to unwanted levels between dialysis treatments.
- Lokelma does not work right away so it should NOT be used as an emergency treatment for life-threatening high potassium levels.
2. Upsides
- Lokelma is used to treat high potassium levels (hyperkalemia) in adults. Normal blood potassium levels are 3.5 to 5 milliequivalents per liter (mEq/L), but may still be considered normal up to 5.2 mEq in some cases. Potassium levels above 6 mEq/L is considered severe and may be life-threatening.
- High potassium in the blood is associated with medical conditions like kidney disease, high blood pressure, heart failure, diabetes, and the side effects of some medications.
- Potassium levels start to decline within one hour after the administration of Lokelma. In studies, normal potassium levels were reached in a median of 2.2 hours. Over 90% of patients had normal potassium levels within 48 hours. In clinical studies, ongoing treatment helped keep potassium levels within a normal range over at least 12 months.
- Lokelma can be used by people who are either on dialysis treatment or not on dialysis treatment. When Lokelma is prescribed for people who are on chronic dialysis treatment, it is only administered on non-dialysis days.
- In studies, Lokelma was effective in lowering potassium levels in patients with chronic kidney disease, heart failure, diabetes and those taking RAAS inhibitors (for example: ACE inhibitors or ARBs).
- Lokelma is taken by mouth as an oral suspension, it has no taste or smell, and does not expand in your digestive tract. It works by binding and removing potassium in the digestive tract so that the potassium does not get into your bloodstream. Lokelma can be taken with or without food.
- Talk to your doctor to determine if you need to follow a low potassium or sodium diet.
- Lokelma is not absorbed into the bloodstream after you take it. Use by a woman during pregnancy or breastfeeding is not expected to result in an exposure to the drug to the unborn child or infant.
- No differences in safety or effectiveness have been observed between older patients (those 65 years of age and older) and younger patients.
3. Downsides
If you are between the ages of 18 and 60, take no other medication or have no other medical conditions, side effects you are more likely to experience include:
- Swelling (edema) in your body (such as hands, ankles, feet) due to fluid retention. Lokelma contains about 400 mg of sodium (“salt”) in each 5 g dose, which can lead to fluid retention and swelling. Mild to moderate swelling is the most common side effect. Ask your doctor if you need to reduce the sodium in your diet or adjust your diuretic (“water pill”) dose, if you take one.
- Some patients with pre-existing heart failure could experience worsening of heart failure due to fluid overload in the body. Symptoms may include increased shortness of breath, swelling of legs or ankles (edema), and rapid weight gain. Patients with pre-existing heart failure should watch for these symptoms, and report them to their healthcare provider if they occur.
- If you take other oral medications in addition to Lokelma, you may need to take them 2 hours before or 2 hours after taking Lokelma, as directed by your healthcare provider.
- Tell your doctor before you start treatment if you have trouble with your bowel movements, for example: severe constipation, a blockage (obstruction) in your bowel, a dry, hard stool that will not pass out of your rectum (impaction), or problems with your bowels or bowel movements after surgery.
- If you receive dialysis, you may be prone to illnesses that increase your risk for losing potassium from your body (for example, illnesses associated with decreased food or fluid intake, or diarrhea). If you feel sick, tell your doctor, as your dose of Lokelma may need to be adjusted.
- It is not known if this drug is safe or effective in children under 18 years of age. It is approved for use in adults.
This is not a complete list of side effects, precautions or warnings, and others may occur. Call your doctor for medical advice about side effects, precautions or warnings.
Note: In general, seniors or children, people with certain medical conditions (such as liver or kidney problems, heart disease, diabetes, seizures) or people who take other medications are more at risk of developing a wider range of side effects. View complete list of side effects
4. Bottom Line
Lokelma is used to treat high potassium levels (hyperkalemia) in adults, including patients who are on dialysis. High potassium in the blood is associated with medical conditions like kidney disease, high blood pressure, heart failure, diabetes, and the side effects of some medications. Lokelma does not work right away so it should NOT be used as an emergency treatment for life-threatening high potassium levels. In general, other oral medications should be administered at least 2 hours before or 2 hours after Lokelma.
5. Tips
- Always take Lokelma exactly as your doctor prescribes it. Let your healthcare provider know about all of your medical conditions and medicines that you take before treatment. Contact your doctor if your symptoms worsen or your condition changes. Do not stop any treatment unless your healthcare provider tells you to stop.
- High potassium in your blood can lead to symptoms like muscle fatigue, weakness, a tingling feeling, nausea and vomiting, a dangerous change in your heartbeat, chest pain and paralysis. If you experience any of these symptoms, call 911 or get immediate medical assistance.
- Lokelma is available as a powder for oral suspension. You will learn how to mix this suspension at home. It comes in foil packets of either 5 grams (g) or 10 g for reconstitution. It has no taste or smell. You will mix the powder with a small amount of water before you drink it. It does not expand in water, so it is not expected to swell within the digestive tract. Be sure to drink the entire amount unless otherwise directed by your doctor.
- Look for signs of swelling (edema) in your body especially if you limit sodium in your diet or are likely to have fluid retention in your body due to heart or kidney problems. Your doctor may tell you to reduce the sodium in your diet. If you take a diuretic (“fluid or water pill”) your doctor may direct you to increase your dose of the diuretic.
- If you are a dialysis patient, do not take Lokelma on dialysis days. Tell your doctor if you suddenly feel sick such as a decreased oral intake of food or fluids, or the occurrence of diarrhea. Your Lokelma dose may need to be adjusted.
- Ask your doctor if you need to adjust levels of sodium or potassium in your diet while taking Lokelma. Tell your healthcare provider if you are taking Lokelma before having an abdominal (stomach area) X-ray. This medicine may appear on the X-ray.
- Before you start treatment, tell your healthcare provider if you have problems with having a bowel movement, including severe constipation, a blockage (obstruction) in your bowel, or dry hard stool that will not pass out of your rectum (impaction). Let them know if you have had problems with your bowels after surgery.
- The manufacturer AstraZeneca offers a Savings Card that may reduce your copays to $0 if you qualify (restrictions may apply). You can download your savings card online from the manufacturer's website and no activation is required. They also offer additional educational resources. The manufacturer can answer questions your insurance coverage and connect you with affordability programs. In the U.S., call 1-844-LOKELMA (1-844-565-3562), Monday – Friday, 8 am to 8 pm ET.
6. Response and effectiveness
- In clinical studies, patients received 10 grams of Lokelma 3 times per day for up to 48 hours. Reductions in serum potassium levels were observed within one hour, and potassium levels continued to decline over 48 hours. Normal potassium levels in the blood were reached in a median time of 2.2 hours. Most patients (92%) had normal potassium levels within 48 hours. In patients who did not continue therapy, potassium levels increased.
- The effectiveness of Lokelma in lowering potassium levels was shown in a double-blind, randomized, placebo-controlled study with 753 patients who received 1 of 4 doses of (1.25, 2.5, 5 or 10 g) or placebo (an inactive product), given 3 times daily for the first 48 hours with meals. Lokelma met the primary endpoint and showed a greater dose-dependent reduction in serum potassium levels for the 2.5, 5 and 10 g (3 times a day) groups compared to the placebo (p<0.001). In patients administered a 10 g dose 3 times per day, the mean serum potassium reduction was a reduction of 0.7 mEq/L at 48 hours.
- Lokelma was effective in lowering potassium levels in patients with chronic kidney disease, heart failure, diabetes and those taking renin-angiotensin-aldosterone system (RAAS) inhibitors, for example lisinopril (an ACE inhibitor) or losartan (an ARB).
- In a 12-month open-label study in 751 patients with high potassium levels (average potassium level of 5.6 mEq/L), Lokelma continued to lower potassium levels in patients who stayed on treatment. For maintenance treatment, the initial dosage was 5 g once daily and was adjusted to a minimum of 5 g every other day up to maximum of 15 g once daily, based on serum potassium level. The treatment effect on serum potassium was maintained during continued therapy.
- The effectiveness of Lokelma in lowering serum potassium levels was studied in a double-blind, placebo-controlled trial of 196 chronic hemodialysis patients with persistent pre-dialysis hyperkalemia (mean baseline potassium 5.8 mEq/L). Participants were randomized to receive Lokelma 5 g or placebo once daily on non-dialysis days. During the dose adjustment period (first 4 weeks), the dose was adjusted weekly in 5 g increments up to 15 g once daily based on pre-dialysis serum potassium measurement after the long inter-dialytic interval to achieve a pre-dialysis serum potassium level between 4 to 5 mEq/L. The dose reached at the end of the dose-adjustment period was maintained throughout the subsequent 4-week evaluation period.
7. Interactions
- Medicines that interact with Lokelma may either decrease its effect, affect how long it works for, or increase side effects. An interaction between two medications does not always mean that you must stop taking one of the medications; however, sometimes it does. Speak to your doctor about how drug interactions should be managed.
- Lokelma can change the absorption of other oral medicines and reduce their effectiveness or increase toxicity. In general, if you are taking other oral medications, you may need to take them either 2 hours before or 2 hours after you take Lokelma. Ask your doctor or pharmacist for advice about how to take Lokelma if you take other medicines.
- It is thought that Lokelma, by raising the pH of the stomach, can change the absorption of drugs whose solubility is pH-dependent when given with Lokelma.
Most of the Lokelma interactions are considered moderate in severity. Common medications that may interact with Lokelma include:
atazanavir
- atorvastatin
- dabigatran
- dasatinib
- erlotinib
- furosemide
- indinavir
- itraconazole
- ketoconazole
- levoketoconazole
- nelfinavir
- nilotinib
- posaconazole
- raltegravir
- rilpivirine
- ritonavir
- saquinavir
- tacrolimus
It is important to tell your doctor about all medications you use, including prescription, over-the-counter (OTC), vitamins and herbal or other dietary supplements. Do not stop using any medications without first talking to your doctor.
Note that this list is not all-inclusive and includes only common medications that may interact with Lokelma. You should refer to the prescribing information for Lokelma for a complete list of interactions and speak with your doctor or pharmacist.
Related/similar drugs
Humulin R
Humulin R is a man-made insulin that is used to control high blood sugar in adults and children ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Veltassa
Veltassa (patiromer) is a medicine that binds itself to potassium in your digestive tract. This ...
Novolin R
Novolin R is used for diabetes, type 1, diabetic ketoacidosis, gestational diabetes, growth hormone ...
Humulin R U-500 KwikPen
Humulin R U-500 KwikPen is used for diabetes, type 1, type 2 diabetes
Insulin regular
Insulin lowers the level of glucose in the blood and is used to treat type 1 diabetes. Learn about ...
Sodium bicarbonate
Sodium bicarbonate is used for acidosis, alkylating agent cystitis, asystole, diabetic ...
Frequently asked questions
More about Lokelma (sodium zirconium cyclosilicate)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: cation exchange resins
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
References
- Lokelma [product information]. AstraZeneca. Wilmington, DE. Revised Sept. 2022. Accessed June 18, 2025 at https://drd9vrdh9yh09.cloudfront.net/50fd68b9-106b-4550-b5d0-12b045f8b184/6de8f71b-d3af-4f76-9600-907c98616be6/6de8f71b-d3af-4f76-9600-907c98616be6_viewable_rendition__v.pdf
- Lokelma.com. Patient site (FAQs). AstraZeneca. Wilmington, DE. Accessed June 18, 2025 at https://www.lokelma.com/
Further information
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use lokelma only for the indication prescribed.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Copyright 1996-2025 Drugs.com. Revision date: June 18, 2025.